Prolactin and growth hormone mRNA and protein characterization in SMtTW rat pituitary tumours. 1995

M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
Pharmacology Department, Medical School, Free University of Brussels (VUB), Belgium.

We have combined different techniques to analyse passages of five different rat spontaneous pituitary tumours (SMtTW) that were transplanted under the kidney capsule. These tumours were secreting prolactin (PRL), GH or both hormones. RIA, immunocytochemistry (ICC) and Western blot analysis were applied to characterize the hormone(s) stored (ICC and Western blot) and secreted (RIA). mRNA content was analysed by PCR, Northern blot analysis and in situ hybridization. The data point not only to the reliability of the techniques used at both protein and RNA levels for each tumour studied but also to the complementarity of some techniques. For example, whereas Northern blot analysis demonstrates the presence and size of hormone mRNA, in situ hybridization indicates the percentage of cells expressing a given hormone mRNA and allows the presence of one population (or more) of cells in a given tumour to be identified. Moreover, the tumours were compared with normal rat pituitary. Although the PRL and GH mRNAs were identical in size, the amount of mRNA was lower in the tumours. At the protein level, the PRL and GH variants exhibited a different pattern of expression in tumours compared with the normal rat pituitary. The biological significance of these differences is discussed.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011920 Rats, Inbred WF An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Wistar Furth,Rats, Wistar Furth,Rats, WF,Inbred WF Rat,Inbred WF Rats,Rat, Inbred WF,Rat, WF,WF Rat,WF Rat, Inbred,WF Rats,WF Rats, Inbred,Wistar Furth Rats
D005260 Female Females

Related Publications

M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
January 1980, Acta oto-laryngologica,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
January 1990, Acta neurochirurgica. Supplementum,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
October 1973, Science (New York, N.Y.),
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
July 1977, Lancet (London, England),
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
November 1988, The American journal of pathology,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
June 1985, The Journal of biological chemistry,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
May 1983, The Journal of endocrinology,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
February 1977, Endocrinology,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
October 1993, Journal of molecular endocrinology,
M Delhase, and F Rajas, and P Verdood, and C Remy, and P Chevallier, and B Velkeniers, and J Trouillas, and E L Hooghe-Peters
July 1980, The Journal of endocrinology,
Copied contents to your clipboard!